Magnetic resonance imaging features of fibrocystic change of the breast

Wu, 2004, A case-control study of risk factors for fibrocystic breast conditions, Am J Epidemiol, 160, 945, 10.1093/aje/kwh318 DiPiro, 2000, Mammography and sonographic appearances of nodular adenosis, Am J Roentgenol, 175, 31, 10.2214/ajr.175.1.1750031 Harvey, 1999, Fibrous nodules found at large-core needle biopsy of the breast: imaging features, Radiology, 211, 535, 10.1148/radiology.211.2.r99ma42535 Warner, 1998, Apocrine metaplasia: mammography and sonographic appearances, Am J Roentgenol, 170, 1375, 10.2214/ajr.170.5.9574619 van den Bosch, 2005, Magnetic resonance imaging characteristics of fibrocystic change of the breast, Invest Radiol, 40, 436, 10.1097/01.rli.0000167123.26334.c8 Kvistad, 1999, Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy, J Magn Reson Imaging, 10, 159, 10.1002/(SICI)1522-2586(199908)10:2<159::AID-JMRI8>3.0.CO;2-0 Su, 2005, Pharmacokinetic parameters analyzed from MR contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients, Technol Cancer Res Treat, 4, 255, 10.1177/153303460500400305 Bottomley, 1987, Spatial localization in NMR spectroscopy in vivo, Ann NY Acad Sci, 508, 333, 10.1111/j.1749-6632.1987.tb32915.x Bolan, 2003, In vivo quantification of choline compounds in the breast with 1H MR spectroscopy, Magn Reson Med, 50, 1134, 10.1002/mrm.10654 Baik, 2006, Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T, MAGMA, 19, 96, 10.1007/s10334-006-0032-4 Jacobs, 2004, Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study, J Magn Reson Imaging, 19, 68, 10.1002/jmri.10427 American College of Radiology, 2003 Ercolani, 1998, Dynamic MRI of the breast, Eur J Radiol, 27, 265, 10.1016/S0720-048X(98)00073-4 Esserman, 1999, Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma, Breast J, 5, 13, 10.1046/j.1524-4741.1999.005001013.x Kaiser, 1989, MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations, Radiology, 170, 681, 10.1148/radiology.170.3.2916021 Ikeda, 2001, Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies, J Magn Reson Imaging, 13, 889, 10.1002/jmri.1127 Shetty, 2002, Sonographic findings in focal fibrocystic changes of the breast, Ultrasound Q, 18, 35, 10.1097/00013644-200203000-00004 Müller-Schimpfle, 1997, Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast, Radiology, 203, 145, 10.1148/radiology.203.1.9122383 Goto, 2007, Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features, J Magn Reson Imaging, 25, 104, 10.1002/jmri.20812 Liberman, 2006, Does size matter? Positive predictive value of MRI detected breast lesions as a function of lesion size, Am J Roentgenol, 186, 426, 10.2214/AJR.04.1707 Yabuuchi, 2006, Incidentally detected lesions on contrast-enhanced MR imaging in candidates for breast-conserving therapy: correlation between MR findings and histological diagnosis, J Magn Reson Imaging, 23, 486, 10.1002/jmri.20532 Lehman, 2007, MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer, N Engl J Med, 356, 1295, 10.1056/NEJMoa065447 Kim, 2003, In vivo 1H-MRS evaluation of malignant and benign breast diseases, Breast, 12, 179, 10.1016/S0960-9776(03)00012-2